Impact of telemedical management on hospitalization and mortality in heart failure patients with diabetes: a post-hoc subgroup analysis of the TIM-HF2 trial

Scholte NTB, Gurgoze MT, Aydin D, Theuns D, Manintveld OC, Ronner E, Boersma E, de Boer RA, van der Boon RMA, Brugts JJ. Telemonitoring for heart failure: a meta-analysis. Eur Heart J. 2023;44:2911–26.

Article  PubMed  PubMed Central  Google Scholar 

Koehler F, Koehler K, Deckwart O, Prescher S, Wegscheider K, Kirwan BA, Winkler S, Vettorazzi E, Bruch L, Oeff M, Zugck C, Doerr G, Naegele H, Stork S, Butter C, Sechtem U, Angermann C, Gola G, Prondzinsky R, Edelmann F, Spethmann S, Schellong SM, Schulze PC, Bauersachs J, Wellge B, Schoebel C, Tajsic M, Dreger H, Anker SD, Stangl K. Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial. Lancet. 2018;392:1047–57.

Article  PubMed  Google Scholar 

Pandey A, Khan MS, Patel KV, Bhatt DL, Verma S. Predicting and preventing heart failure in type 2 diabetes. Lancet Diabetes Endocrinol. 2023.

MacDonald MR, Petrie MC, Varyani F, Ostergren J, Michelson EL, Young JB, Solomon SD, Granger CB, Swedberg K, Yusuf S, Pfeffer MA, McMurray JJ, Investigators C. Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of reduction in mortality and morbidity (CHARM) programme. Eur Heart J. 2008;29:1377–85.

Article  PubMed  Google Scholar 

Lehrke M, Marx N. Diabetes Mellitus and Heart failure. Am J Med. 2017;130:S40–50.

Article  CAS  PubMed  Google Scholar 

ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, Collins BS, Hilliard ME, Isaacs D, Johnson EL, Kahan S, Khunti K, Leon J, Lyons SK, Perry ML, Prahalad P, Pratley RE, Seley JJ, Stanton RC, Gabbay RA. On behalf of the American Diabetes A. 1. Improving Care and promoting health in populations: standards of Care in Diabetes-2023. Diabetes Care. 2023;46:S10–8.

Article  PubMed  Google Scholar 

Koehler F, Koehler K, Deckwart O, Prescher S, Wegscheider K, Winkler S, Vettorazzi E, Polze A, Stangl K, Hartmann O, Marx A, Neuhaus P, Scherf M, Kirwan BA, Anker SD. Telemedical Interventional Management in Heart failure II (TIM-HF2), a randomised, controlled trial investigating the impact of telemedicine on unplanned cardiovascular hospitalisations and mortality in heart failure patients: study design and description of the intervention. Eur J Heart Fail. 2018;20:1485–93.

Article  PubMed  Google Scholar 

Bradley J, Schelbert EB, Bonnett LJ, Lewis GA, Lagan J, Orsborne C, Brown PF, Naish JH, Williams SG, McDonagh T, Schmitt M, Miller CA. Predicting hospitalisation for heart failure and death in patients with, or at risk of, heart failure before first hospitalisation: a retrospective model development and external validation study. Lancet Digit Health. 2022;4:e445–54.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Inglis SC, Clark RA, Dierckx R, Prieto-Merino D, Cleland JG. Structured telephone support or non-invasive telemonitoring for patients with heart failure. Cochrane Database Syst Rev. 2015;2015:CD007228.

PubMed  PubMed Central  Google Scholar 

Zhu Y, Gu X, Xu C. Effectiveness of telemedicine systems for adults with heart failure: a meta-analysis of randomized controlled trials. Heart Fail Rev. 2020;25:231–43.

Article  CAS  PubMed  Google Scholar 

Scholte NTB, Gurgoze MT, Aydin D, Theuns D, Manintveld OC, Ronner E, Boersma E, de Boer RA, van der Boon RMA, Brugts JJ. Telemonitoring for heart failure: a meta-analysis. Eur Heart J. 2023.

Yanicelli LM, Goy CB, Martínez EC, Herrera MC. Heart failure non-invasive home telemonitoring systems: a systematic review. Comput Methods Programs Biomed. 2021;201:105950.

Article  PubMed  Google Scholar 

Alvarez P, Sianis A, Brown J, Ali A, Briasoulis A. Chronic disease management in heart failure: focus on telemedicine and remote monitoring. Rev Cardiovasc Med. 2021;22:403–13.

Article  PubMed  Google Scholar 

Brahmbhatt DH, Cowie MR. Remote management of Heart failure: an overview of Telemonitoring technologies. Card Fail Rev. 2019;5:86–92.

Article  PubMed  PubMed Central  Google Scholar 

Galinier M, Roubille F, Berdague P, Brierre G, Cantie P, Dary P, Ferradou JM, Fondard O, Labarre JP, Mansourati J, Picard F, Ricci JE, Salvat M, Tartiere L, Ruidavets JB, Bongard V, Delval C, Lancman G, Pasche H, Ramirez-Gil JF, Pathak A, Investigators O. Telemonitoring versus standard care in heart failure: a randomised multicentre trial. Eur J Heart Fail. 2020;22:985–94.

Article  PubMed  Google Scholar 

Ong MK, Romano PS, Edgington S, Aronow HU, Auerbach AD, Black JT, De Marco T, Escarce JJ, Evangelista LS, Hanna B, Ganiats TG, Greenberg BH, Greenfield S, Kaplan SH, Kimchi A, Liu H, Lombardo D, Mangione CM, Sadeghi B, Sadeghi B, Sarrafzadeh M, Tong K, Fonarow GC. Better Effectiveness after Transition-Heart Failure Research G. Effectiveness of Remote Patient Monitoring after discharge of hospitalized patients with heart failure: the Better Effectiveness after transition -- heart failure (BEAT-HF) randomized clinical trial. JAMA Intern Med. 2016;176:310–8.

Article  PubMed  PubMed Central  Google Scholar 

Felker GM, Sharma A, Mentz RJ, She L, Green CL, Granger BB, Heitner JF, Cooper L, Teuteberg J, Grodin JL, Rosenfield K, Hudson L, Kwee LC, Ilkayeva O, Shah SH. A Randomized Controlled Trial of Mobile Health Intervention in patients with heart failure and diabetes. J Card Fail. 2022;28:1575–83.

Article  PubMed  Google Scholar 

Silva-Almodovar A, Nahata MC. Telehealth intervention to improve uptake of evidence-based medications among patients with type 2 diabetes and heart failure or Cardiovascular Disease. Int J Environ Res Public Health. 2023;20.

Glowczynska R, Piotrowicz E, Szalewska D, Piotrowicz R, Kowalik I, Pencina MJ, Zareba W, Banach M, Orzechowski P, Pluta S, Irzmanski R, Kalarus Z, Opolski G. Effects of hybrid comprehensive telerehabilitation on cardiopulmonary capacity in heart failure patients depending on diabetes mellitus: subanalysis of the TELEREH-HF randomized clinical trial. Cardiovasc Diabetol. 2021;20:106.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Drug Commission of German Pharmacists (AMK) DCotGMAA, Federal Association for Self-Help (BAG Selbsthilfe), German Diabetes Society (DDG), German Society for General Medicine and Family Medicine (DEGAM), German Society for Geriatrics (DGG), German Society For Internal Medicine (DGIM), German Society for Internal Intensive Care Medicine and Emergency Medicine (DGIIN), German Society for Cardiology-Heart and Circulation Research (DGK), German Society for Nephrology (DGFN), German Society for Palliative Medicine (DGP), German Society for Nursing Science (DGP), German Society for Pneumology and Respiratory Medicine (DGP), German Society for the Prevention and Rehabilitation of Cardiovascular Diseases (DGPR), German Society for Psychosomatic Medicine and Medical Psychotherapy (DGPM), German Society for Rehabilitation Sciences (DGRW), German Society for Sleep Research and Sleep Medicine (DGSM), German Society for Thoracic, Cardiac and Vascular Surgery (DGTHG), German College for Psychosomatic Medicine (DKPM), Medical Center for Quality in Medicine (ÄZQ). NVL Chronic Heart Failure– Long Version. 2019;3.

留言 (0)

沒有登入
gif